Table 5.
Steroid profiling in brain (left hemisphere) and plasma of young adult PRloxP/loxP and PRNesCre mice of both sexes
Steroid | PRloxP/loxP |
PRNesCre |
Two-way ANOVA | ||
---|---|---|---|---|---|
Males | Females | Males | Females | ||
Left hemisphere (ng/g) | |||||
Pregnenolone | 9.94 ± 0.61 | 6.84 ± 0.08* | 10.3 ± 0.78 | 6.14 ± 0.17* | Sex: F(1,17) = 20.4; p = 0.0003 |
Genotype: F(1,17) = 0.05; p = 0.825 | |||||
Interaction: F(1,17) = 0.43; p = 0.521 | |||||
Progesterone | 0.73 ± 0.08 | 0.44 ± 0.06 | 0.38 ± 0.14 | 0.46 ± 0.11 | Sex: F(1,17) = 1.09; p = 0.311 |
Genotype: F(1,17) = 2.59; p = 0.126 | |||||
Interaction: F(1,17) = 3.10; p = 0.096 | |||||
5α-DHP | 24.0 ± 5.36 | 5.69 ± 0.95** | 28.3 ± 2.52 | 4.81 ± 0.32** | Sex: F(1,18) = 29.2; p < 0.0001 |
Genotype: F(1,18) = 0.19; p = 0.669 | |||||
Interaction: F(1,18) = 0.44; p = 0.515 | |||||
3α,5α-THP | 3.57 ± 0.79 | 0.53 ± 0.18*** | 1.46 ± 0.20$$ | 0.15 ± 0.03 | Sex: F(1,18) = 31.6; p < 0.0001 |
Genotype: F(1,18) = 10.3; p = 0.005 | |||||
Interaction: F(1,18) = 4.96; p = 0.039 | |||||
20α-DHP | 2.12 ± 0.16 | 22.6 ± 6.42** | 0.90 ± 0.28 | 18.5 ± 1.63* | Sex: F(1,16) = 21.9; p = 0.0003 |
Genotype: F(1,16) = 0.43; p = 0.522 | |||||
Interaction: F(1,16) = 0.13; p = 0.728 | |||||
5α,20α-THP | 1.30 ± 0.20 | 0.64 ± 0.16** | 0.50 ± 0.07$$ | 0.61 ± 0.05 | Sex: F(1,17) = 3.60; p = 0.075 |
Genotype: F(1,17) = 8.38; p = 0.010 | |||||
Interaction: F(1,17) = 7.28; p = 0.015 | |||||
5β-DHP | ND | 0.28 ± 0.04 | ND | 0.30 ± 0.06 | |
3β5α-THP | 0.44 ± 0.10 | 0.01 ± 0.004*** | 0.12 ± 0.02$$$ | 0.01 ± 0.002 | Sex: F(1,17) = 27.4; p < 0.0001 |
Genotype: F(1,17) = 9.49; p = 0.007 | |||||
Interaction: F(1,17) = 9.27; p = 0.007 | |||||
3α5β-THP | 0.03 ± 0.01 | 0.24 ± 0.05** | 0.10 ± 0.02 | 0.34 ± 0.06*** | Sex: F(1,17) = 32.3; p < 0.0001 |
Genotype: F(1,17) = 4.55; p = 0.048 | |||||
Interaction: F(1,17) = 0.30; p = 0.592 | |||||
3α5α20α-HHP | 1.29 ± 0.37 | 0.53 ± 0.10* | 0.35 ± 0.05$ | 0.58 ± 0.04 | Sex: F(1,15) = 1.69; p = 0.213 |
Genotype: F(1,15) = 4.61; p = 0.049 | |||||
Interaction: F(1,15) = 5.82; p = 0.029 | |||||
3β5α20α-HHP | 0.18 ± 0.05 | 0.04 ± 0.01** | 0.04 ± 0.01$$ | 0.03 ± 0.001 | Sex: F(1,15) = 8.63; p = 0.010 |
Genotype: F(1,15) = 7.17; p = 0.017 | |||||
Interaction: F(1,15) = 5.07; p = 0.040 | |||||
3α5β20α-HHP | 0.01 ± 0.003 | 0.07 ± 0.03* | ND | 0.27 ± 0.01***$$$ | |
20α-DHPREG | 0.41 ± 0.02 | 0.30 ± 0.02* | 0.35 ± 0.04 | 0.34 ± 0.01 | Sex: F(1,17) = 5.47; p = 0.032 |
Genotype: F(1,17) = 0.25; p = 0.625 | |||||
Interaction: F(1,17) = 4.16; p = 0.057 | |||||
DOC | 1.78 ± 0.31 | 7.25 ± 1.32*** | 1.11 ± 0.45 | 6.02 ± 0.31** | Sex: F(1,17) = 38.1; p < 0.0001 |
Genotype: F(1,17) = 1.28; p = 0.273 | |||||
Interaction: F(1,17) = 0.11; p = 0.743 | |||||
5α-DHDOC | 0.87 ± 0.24 | 0.67 ± 0.08 | 0.71 ± 0.12 | 0.83 ± 0.11 | Sex: F(1,17) = 0.08; p = 0.786 |
Genotype: F(1,17) = 0.0001; p = 0.992 | |||||
Interaction: F(1,17) = 1.38; p = 0.257 | |||||
5β-DHDOC | ND | 4.11 ± 0.77 | ND | 5.21 ± 0.82 | |
3α5α-THDOC | 0.75 ± 0.05 | 0.06 ± 0.01*** | 0.33 ± 0.06$$$ | 0.12 ± 0.04** | Sex: F(1,18) = 102.2; p < 0.0001 |
Genotype: F(1,18) = 16.2; p = 0.0008 | |||||
Interaction: F(1,18) = 27.5; p < 0.0001 | |||||
3α5β-THDOC | ND | 1.00 ± 0.27 | ND | 1.41 ± 0.29 | |
Corticosterone | 47.6 ± 4.73 | 32.5 ± 4.66 | 19.4 ± 3.05$$$ | 34.2 ± 4.29 | Sex: F(1,18) = 0.001; p = 0.979 |
Genotype: F(1,18) = 9.86; p = 0.006 | |||||
Interaction: F(1,18) = 12.6; p = 0.002 | |||||
Testosterone | 0.09 ± 0.002 | 0.01 ± 0.004* | 0.11 ± 0.03 | 0.01 ± 0.004** | Sex: F(1,14) = 23.7; p = 0.0003 |
Genotype: F(1,14) = 0.41; p = 0.533 | |||||
Interaction: F(1,14) = 0.52; p = 0.482 | |||||
5α-DHT | 0.03 ± 0.01 | 0.02 ± 0.01 | 0.03 ± 0.01 | 0.02 ± 0.01 | Sex: F(1,16) = 2.41; p = 0.141 |
Genotype: F(1,16) = 0.02; p = 0.901 | |||||
Interaction: F(1,16) = 0.15; p = 0.704 | |||||
3α5α-THT | 0.01 ± 0.003 | 0.002 ± 0.00002** | 0.007 ± 0.004 | 0.002 ± 0.00004 | Sex: F(1,16) = 13.3; p = 0.002 |
Genotype: F(1,16) = 1.85; p = 0.193 | |||||
Interaction: F(1,16) = 1.83; p = 0.195 | |||||
Estradiol | 0.02 ± 0.0003 | 0.01 ± 0.002 | 0.01 ± 0.002 | 0.01 ± 0.001 | Sex: F(1,16) = 0.89; p = 0.361 |
Genotype: F(1,16) = 2.24; p = 0.154 | |||||
Interaction: F(1,16) = 3.89; p = 0.066 | |||||
Plasma (ng/ml) | |||||
Pregnenolone | 0.35 ± 0.07 | 0.39 ± 0.02 | 0.23 ± 0.03 | 0.36 ± 0.12 | Sex: F(1,17) = 1.54; p = 0.232 |
Genotype: F(1,17) = 1.33; p = 0.265 | |||||
Interaction: F(1,17) = 0.51; p = 0.486 | |||||
Progesterone | 0.52 ± 0.08 | 0.51 ± 0.09 | 0.43 ± 0.17 | 0.33 ± 0.02 | Sex: F(1,18) = 0.34; p = 0.565 |
Genotype: F(1,18) = 2.46; p = 0.134 | |||||
Interaction: F(1,18) = 0.29; p = 0.598 | |||||
5α-DHP | 9.66 ± 0.61 | 0.57 ± 0.10*** | 8.85 ± 0.66 | 0.67 ± 0.10*** | Sex: F(1,17) = 318.2; p < 0.0001 |
Genotype: F(1,17) = 0.54; p = 0.471 | |||||
Interaction: F(1,17) = 0.90; p = 0.357 | |||||
3α,5α-THP | 2.29 ± 0.47 | 0.18 ± 0.07*** | 0.89 ± 0.06$$$ | 0.19 ± 0.06 | Sex: F(1,16) = 33.3; p < 0.0001 |
Genotype: F(1,16) = 8.05; p = 0.012 | |||||
Interaction: F(1,16) = 8.30; p = 0.011 | |||||
20α-DHP | 1.51 ± 0.19 | 19.3 ± 4.35*** | 0.64 ± 0.11 | 22.3 ± 2.01*** | Sex: F(1,16) = 71.3; p < 0.0001 |
Genotype: F(1,16) = 0.22; p = 0.645 | |||||
Interaction: F(1,16) = 0.71; p = 0.412 | |||||
5α,20α-THP | 0.33 ± 0.10 | 0.17 ± 0.06 | 0.10 ± 0.02 | 0.18 ± 0.01 | Sex: F(1,16) = 0.33; p = 0.575 |
Genotype: F(1,16) = 3.28; p = 0.089 | |||||
Interaction: F(1,16) = 3.96; p = 0.064 | |||||
5β-DHP | ND | 0.11 ± 0.01 | 0.01 ± 0.002 | 0.10 ± 0.02 | |
3β5α-THP | 0.03 ± 0.01 | 0.002 ± 0.001** | 0.005 ± 0.001$$ | 0.004 ± 0.002 | Sex: F(1,17) = 9.21; p = 0.008 |
Genotype: F(1,17) = 6.24; p = 0.023 | |||||
Interaction: F(1,17) = 7.49; p = 0.014 | |||||
3α5β-THP | 0.01 ± 0.002 | 0.24 ± 0.02*** | 0.01 ± 0.002 | 0.31 ± 0.02***$$ | Sex: F(1,13) = 338.9; p < 0.0001 |
Genotype: F(1,13) = 5.62; p = 0.034 | |||||
Interaction: F(1,13) = 5.71; p = 0.033 | |||||
3α5α20α-HHP | 1.02 ± 0.28 | 0.71 ± 0.20 | 0.27 ± 0.02 | 0.50 ± 0.03 | Sex: F(1,16) = 0.04; p = 0.839 |
Genotype: F(1,16) = 6.31; p = 0.023 | |||||
Interaction: F(1,16) = 2.10; p = 0.167 | |||||
3β5α20α-HHP | 0.12 ± 0.04 | 0.03 ± 0.003** | 0.02 ± 0.002$ | 0.02 ± 0.005 | Sex: F(1,15) = 4.28; p = 0.056 |
Genotype: F(1,15) = 6.74; p = 0.020 | |||||
Interaction: F(1,15) = 4.61; p = 0.049 | |||||
3α5β20α-HHP | ND | 0.14 ± 0.06* | ND | 0.32 ± 0.02***$$ | |
20α -DHPREG | 0.02 ± 0.003 | 0.02 ± 0.005 | 0.02 ± 0.004 | 0.02 ± 0.003 | Sex: F(1,16) = 0.39; p = 0.540 |
Genotype: F(1,16) = 2.18; p = 0.160 | |||||
Interaction: F(1,16) = 0.14; p = 0.715 | |||||
DOC | 0.15 ± 0.03 | 0.63 ± 0.22 | 0.14 ± 0.05 | 0.83 ± 0.25* | Sex: F(1,18) = 12.1; p = 0.003 |
Genotype: F(1,17) = 0.30; p = 0.593 | |||||
Interaction: F(1,17) = 0.43; p = 0.518 | |||||
5α-DHDOC | 5.09 ± 1.31 | 1.26 ± 0.12* | 3.34 ± 0.83 | 1.13 ± 0.22 | Sex: F(1,16) = 12.7; p = 0.003 |
Genotype: F(1,16) = 1.24; p = 0.282 | |||||
Interaction: F(1,16) = 0.92; p = 0.352 | |||||
5β-DHDOC | ND | 1.87 ± 0.33 | ND | 3.99 ± 1.60 | |
3α5α-THDOC | 0.97 ± 0.24 | 0.02 ± 0.01** | 0.57 ± 0.14 | 0.06 ± 0.02 | Sex: F(1,15) = 20.4; p = 0.0004 |
Genotype: F(1,15) = 1.24; p = 0.283 | |||||
Interaction: F(1,15) = 1.87; p = 0.192 | |||||
3α5β-THDOC | <0.005 | 0.14 ± 0.04 | <0.005 | 0.58 ± 0.27 | |
Corticosterone | 82.1 ± 4.78 | 65.1 ± 11.2 | 46.8 ± 6.20$ | 76.2 ± 6.72 | Sex: F(1,17) = 0.55; p = 0.469 |
Genotype: F(1,17) = 2.09; p = 0.167 | |||||
Interaction: F(1,17) = 7.64; p = 0.013 | |||||
Testosterone | 0.10 ± 0.02 | 0.002 ± 0.00003*** | 0.11 ± 0.03 | 0.01 ± 0.005*** | Sex: F(1,17) = 46.1; p < 0.0001 |
Genotype: F(1,17) = 0.42; p = 0.523 | |||||
Interaction: F(1,17) = 0.01; p = 0.913 | |||||
5α-DHT | 0.01 ± 0.001 | 0.002 ± 0.00002*** | 0.01 ± 0.003 | 0.002 ± 0.00003** | Sex: F(1,17) = 36.5; p < 0.0001 |
Genotype: F(1,17) = 0.84; p = 0.373 | |||||
Interaction: F(1,17) = 0.78; p = 0.389 | |||||
3α5α-THT | 0.02 ± 0.002 | 0.003 ± 0.001* | 0.03 ± 0.004 | 0.01 ± 0.01* | Sex: F(1,17) = 17.7; p = 0.0006 |
Genotype: F(1,17) = 2.72; p = 0.117 | |||||
Interaction: F(1,17) = 0.002; p = 0.969 | |||||
Estradiol | 0.01 ± 0.001 | 0.01 ± 0.001 | 0.01 ± 0.001 | 0.01 ± 0.003 | Sex: F(1,17) = 0.11; p = 0.741 |
Genotype: F(1,17) = 0.31; p = 0.587 | |||||
Interaction: F(1,17) = 2.30; p = 0.148 |
Results are presented as means ± SEM (n = 5–6 per group) and were analyzed by two-way ANOVA (sex × genotype) for brain and plasma followed by Newman–Keuls multiple-comparisons tests.
***p < 0.001,
**p < 0.01,
*p < 0.05 versus males; $$$p < 0.001, $$p < 0.01, $$p < 0.05 versus PRloxP/loxP.
Abbreviations of steroids are as for Table 1. ND, Not detected.